Uncategorized
-
Health & MedicineDiabetes drug might hike heart risk
People who take rosiglitazone, a popular diabetes drug marketed as Avandia, may face an increased risk of heart attack.
By Nathan Seppa -
19844
Your article reports 86 heart attacks among 15,560 rosiglitazone (Avandia) users, versus 72 others in a control group of 12,283. A study coauthor then says that “after statistical adjustment, that yields a 43 percent higher risk of heart attacks among rosiglitazone users.” Simple arithmetic would seem to indicate it was the control group that had […]
By Science News -
Health & MedicineStents Stumble
After a meteoric rise, stents coated with drugs to prevent renarrowing of clogged arteries have begun to fall from favor among cardiologists.